Oceanía · Mercados regionales · The Motley Fool Australia

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Publicado por The Motley Fool Australia · Australia hace 2 h

Telix Pharmaceuticals' Q3 2026 update sees strong revenue growth, FDA milestones, and a major merger to expand its radiopharmaceuticals platform. The post Telix Pharmaceuticals Q3…

Leer el artículo completo en The Motley Fool Australia Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com.au)

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

También te puede interesar

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Telix Pharmaceuticals Q3 2026 earnings: revenue up, pipeline advances

Compartir

También te puede interesar

Woodside confirms plan to sell down $3.3b project after two years of ownership

GAMING: 6 of the best indie games from the PAX Australia show floor

Transport costs to Sydney's new airport: Is it worth it for you?

Mino Founder Mel Moss On How Her Son’s Sleep Problems Led To A New Bedding Business

Morning Wrap: ASX 200 to rise, Dow rallies on defensive pivot, S&P 500 gains on oil retreat

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail